首页> 中文期刊> 《现代临床医学》 >金双歧联合思密达治疗小儿腹泻疗效观察

金双歧联合思密达治疗小儿腹泻疗效观察

         

摘要

目的::探讨联合应用金双歧和思密达治疗小儿腹泻的疗效。方法:选取2013年2月至2014年2月于我院儿科门诊就诊的120例腹泻患者为观察对象。随机将患者分为观察组和对照组,每组各60例。对照组予常规治疗,观察组在常规治疗的基础上采用金双歧与思密达联合治疗。3d后观察疗效。结果:观察组患者临床症状改善时间显著短于对照组(P<0.05)。总有效率观察组为96.67%,对照组为73.33%,2组比较有显著性差异(P<0.05)。2组患者在治疗过程中均未出现明显的不良反应。结论:金双歧和思密达协同治疗小儿腹泻效果确切,值得临床推广应用。%Objective:To study the effect of combination of Golden Bifidobacterium and smecta in treatment of infantile diarrhea;to improve the ways of clinical application. Methods:120 children with diarrhea were divided into treatment group and control group randomly ( n =60 ) . The control group was given conventional treatment, while the treatment group was given combination of Golden Bifidobacterium and smecta on the basis of routine therapy. The therapeutic effect of both groups were compared in 3 days. Results:The time of clinic symptom improvedin the treatment group was significantly shorter than that in the control group,the difference had statistically significant(P<0. 05). The efficiency of the treatment group was 85% while the total effective rate was 96. 67%. The efficiency of the control group was 61. 67% while the the total effective rate was 73. 33%. Compared with the control group, the treatment group was higher efficiency than that,the difference had statistically significant ( P<0. 05);there was no adverse reactions in the process of treating in two groups. Conclusion:It is effect of combination of Golden Bifidobacterium and smecta in treatment of infantile diarrhea, it also can reduce the side-effect and worth clinical application.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号